For high risk/high impact projects that have the potential to change current diagnostic or treatment paradigms for either adult or pediatric brain tumors. Discovery-driven science and proof-of-concept studies are encouraged to apply, particularly those with no or little history of previous funding. Priority will be given to concepts focused on experimental therapeutics and experimental therapeutics with reduced toxicities.
ABTA seeks proposals addressing all types of brain tumors, benign or malignant, primary or secondary. Basic molecular biology studies and translational projects are excluded from eligibility for this award. Concepts must focus on new, novel diagnostic or therapeutic approaches.